Androgen receptor mutations in patients with castration-resistant prostate cancer treated with apalutamide.

Written by

Rathkopf DE, Smith MR, Ryan CJ, Berry WR, Liu G, Higano CS, Alumkal JJ, 
Hauke R, Tutrone RF, Saleh M, Chow Maneval E, Thomas S, Ricci DS, Yu MK,
de Boer CJ, Trinh A, Kheoh T, Bandekar R, Scher HI, Antonarakis ES.